• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters1
15,042 results

Regeneron Pharmaceuticals, Inc. v. Sandoz, Inc.

Docket 1:24-cv-00085, West Virginia Northern District Court (Sept. 13, 2024)
Chief District Judge Thomas S Kleeh, presiding
Patent
DivisionClarksburg
Cause15:1126 Patent Infringement
Case Type830 Patent
Tags830 Patent, 830 Patent
Plaintiff Regeneron Pharmaceuticals, Inc.
Defendant Sandoz Inc.
Defendant Sandoz, Inc.
...
cite Cite Docket
Analyze

In Re: Aflibercept Patent Litigation

Docket 1:24-md-03103, West Virginia Northern District Court (Apr. 11, 2024)
Chief District Judge Thomas S Kleeh, presiding, Magistrate Judge James P. Mazzone
Patent
DivisionClarksburg
FlagsAPPEAL
Cause28:1338 Patent Infringement
Case Type830 Patent
Tags830 Patent, 830 Patent
DeadlineAppeal Record due by 7/21/2025.
In Re AFLIBERCEPT PATENT LITIGATION
Plaintiff Regeneron Pharmaceuticals, Inc.
Defendant Mylan Pharmaceuticals Inc.
...
cite Cite Docket
Analyze

OssiFi-Mab LLC v. Amgen Inc.

Docket 1:23-cv-10861, Massachusetts District Court (Apr. 21, 2023)
Judge Denise J. Casper, presiding
Patent
DivisionBoston
FlagsPATENT
Cause35:271 Patent Infringement
Case Type830 Patent
Tags830 Patent, 830 Patent
Patent11608373; 11807681; 8178099; 8877196; 9352043, 11608373, 11807681, 8178099, 8877196, 9352043
DeadlineExpert discovery to be completed by 4/11/25.
DeadlineMotions for Summary Judgment to be filed by 5/8/25 with opposition due 6/5/25.
Plaintiff OssiFi-Mab LLC
Defendant Amgen Inc.
Counter Claimant Amgen Inc.
...
cite Cite Docket
Analyze

AbbVie Inc. et al v. Alkem Laboratories Limited et al

Docket 1:22-cv-01423, Delaware District Court (Oct. 27, 2022)
Judge Jennifer L. Hall, presiding
Patent - Abbreviated New Drug Application (ANDA)
DivisionWilmington
FlagsLEAD, PATENT
Cause35:271 Patent Infringement
Case Type835 Patent - Abbreviated New Drug Application (ANDA)
Tags835 Patent, Abbreviated New Drug Application, Anda, 835 Patent, Abbreviated New Drug Application, Anda
DeadlineClose of Expert Discovery on 4/10/2025
DeadlineDaubert Motions due by 4/17/2025).
Plaintiff AbbVie Inc.
Plaintiff AbbVie Ltd.
Plaintiff Neurocrine Biosciences, Inc.
...
cite Cite Docket
Analyze

Regeneron Pharmaceuticals, Inc. v. Novartis Pharma AG

Docket IPR2021-00816, Patent Trial and Appeal Board (Apr. 16, 2021)
Erica Franklin, Jamie Wisz, Kristi Sawert, Robert Kinder, presiding
Case TypeInter Partes Review
Patent9220631
Patent Owner Novartis Pharma AG
Petitioner Regeneron Pharmaceuticals, Inc.
Patent Owner Novartis Pharmaceuticals
cite Cite Docket
Analyze

Regeneron Pharmaceuticals, Inc. v. Novartis Pharma AG

Docket IPR2020-01317, Patent Trial and Appeal Board (July 16, 2020)
Erica Franklin, Kristi Sawert, Robert Kinder, presiding
Case TypeInter Partes Review
Patent9220631
Patent Owner Novartis Pharma AG
Petitioner Regeneron Pharmaceuticals, Inc.
Patent Owner Novartis Technology
...
cite Cite Docket
Analyze

Regeneron Pharmaceuticals, Inc. v. Novartis Pharma AG

Docket IPR2020-01318, Patent Trial and Appeal Board (July 16, 2020)
Erica Franklin, Kristi Sawert, Robert Kinder, presiding
Case TypeInter Partes Review
Patent9220631
Patent Owner Novartis Pharma AG
Petitioner Regeneron Pharmaceuticals, Inc.
cite Cite Docket
Analyze

Certain Pre-Filled Syringes for Intravitreal Injection and Components Thereof

Docket 337-1207, United States International Trade Commission (June 19, 2020)
Clark S. Cheney, presiding
Case TypeSec 337
Bausch Health
Becton
Complainant Company
...
cite Cite Docket
Analyze
1 2 3 4 5 ... >>